| Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators New England Journal of Medicine 345 (7), 494-502, 2001 | 8612 | 2001 |
| Antiinflammatory therapy with canakinumab for atherosclerotic disease PM Ridker, BM Everett, T Thuren, JG MacFadyen, WH Chang, ... New England journal of medicine 377 (12), 1119-1131, 2017 | 7685 | 2017 |
| Dapagliflozin in patients with heart failure and reduced ejection fraction JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ... New England Journal of Medicine 381 (21), 1995-2008, 2019 | 5621 | 2019 |
| Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ... The Lancet 394 (10193), 121-130, 2019 | 2228 | 2019 |
| Long-term use of ticagrelor in patients with prior myocardial infarction MP Bonaca, DL Bhatt, M Cohen, PG Steg, RF Storey, EC Jensen, ... New England Journal of Medicine 372 (19), 1791-1800, 2015 | 2134 | 2015 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes Fifth Organization to Assess Strategies in Acute Ischemic Syndromes ... New England Journal of Medicine 354 (14), 1464-1476, 2006 | 1466 | 2006 |
| Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo … PM Ridker, JG MacFadyen, T Thuren, BM Everett, P Libby, RJ Glynn, ... The Lancet 390 (10105), 1833-1842, 2017 | 1156 | 2017 |
| Vorapaxar in the secondary prevention of atherothrombotic events DA Morrow, E Braunwald, MP Bonaca, SF Ameriso, AJ Dalby, MP Fish, ... New England Journal of Medicine 366 (15), 1404-1413, 2012 | 1105 | 2012 |
| Prasugrel versus clopidogrel for acute coronary syndromes without revascularization MT Roe, PW Armstrong, KAA Fox, HD White, D Prabhakaran, ... New England journal of medicine 367 (14), 1297-1309, 2012 | 1081 | 2012 |
| Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19 ATTACC, ACTIV-4a, and REMAP-CAP Investigators New England Journal of Medicine 385 (9), 790-802, 2021 | 1011 | 2021 |
| Myocardial viability and survival in ischemic left ventricular dysfunction RO Bonow, G Maurer, KL Lee, TA Holly, PF Binkley, P Desvigne-Nickens, ... New England Journal of Medicine 364 (17), 1617-1625, 2011 | 951 | 2011 |
| Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both SD Solomon, S Zelenkofske, JJV McMurray, PV Finn, E Velazquez, G Ertl, ... New England Journal of Medicine 352 (25), 2581-2588, 2005 | 945 | 2005 |
| Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial SS Anand, J Bosch, JW Eikelboom, SJ Connolly, R Diaz, P Widimsky, ... The Lancet 391 (10117), 219-229, 2018 | 924 | 2018 |
| Thrombin-receptor antagonist vorapaxar in acute coronary syndromes P Tricoci, Z Huang, C Held, DJ Moliterno, PW Armstrong, F Van de Werf, ... New England Journal of Medicine 366 (1), 20-33, 2012 | 894 | 2012 |
| Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled … PM Ridker, JG MacFadyen, BM Everett, P Libby, T Thuren, RJ Glynn, ... The Lancet 391 (10118), 319-328, 2018 | 801 | 2018 |
| Evacetrapib and cardiovascular outcomes in high-risk vascular disease AM Lincoff, SJ Nicholls, JS Riesmeyer, PJ Barter, HB Brewer, KAA Fox, ... New England Journal of Medicine 376 (20), 1933-1942, 2017 | 727 | 2017 |
| IV Diretriz brasileira sobre dislipidemias e prevenção da aterosclerose: Departamento de Aterosclerose da Sociedade Brasileira de Cardiologia AC Sposito, B Caramelli, FAH Fonseca, MC Bertolami, A Afiune Neto, ... Arquivos brasileiros de cardiologia 88, 2-19, 2007 | 693 | 2007 |
| Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient … C Held, N Åsenblad, JP Bassand, RC Becker, CP Cannon, MJ Claeys, ... Journal of the American College of Cardiology 57 (6), 672-684, 2011 | 688 | 2011 |
| Cardiovascular efficacy and safety of bococizumab in high-risk patients PM Ridker, J Revkin, P Amarenco, R Brunell, M Curto, F Civeira, ... New England Journal of Medicine 376 (16), 1527-1539, 2017 | 654 | 2017 |
| V Diretriz da Sociedade Brasileira de Cardiologia sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST LS Piegas, A Timerman, GS Feitosa, JC Nicolau, LAP Mattos, ... Arquivos brasileiros de cardiologia 105, 1-121, 2015 | 588 | 2015 |
